Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel- and lectin-based proteomics analyses
Diagnosis of prostate cancer (PCa) is currently much reliant on the invasive and time-consuming transrectal ultrasound-guided biopsy of the prostate gland, particularly in light of the inefficient use of prostate-specific antigen as its biomarker. In the present study, we have profiled the sera of p...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
2012
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/3461/1/Identification_of_potential_complementary_serum_biomarkers_to_differentiate_prostate_cancer_from_benign_prostatic_hyperplasia_using_gel-.pdf http://eprints.um.edu.my/3461/ http://onlinelibrary.wiley.com/doi/10.1002/elps.201100608/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.um.eprints.3461 |
---|---|
record_format |
eprints |
spelling |
my.um.eprints.34612019-10-24T08:27:05Z http://eprints.um.edu.my/3461/ Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel- and lectin-based proteomics analyses Jayapalan, J.J. Ng, K.L. Razack, A.H.A. Hashim, Onn Haji R Medicine Diagnosis of prostate cancer (PCa) is currently much reliant on the invasive and time-consuming transrectal ultrasound-guided biopsy of the prostate gland, particularly in light of the inefficient use of prostate-specific antigen as its biomarker. In the present study, we have profiled the sera of patients with PCa and benign prostatic hyperplasia (BPH) using the gel- and lectin-based proteomics methods and demonstrated the significant differential expression of apolipoprotein AII, complement C3 beta chain fragment, inter-alpha-trypsin inhibitor heavy chain 4 fragment, transthyretin, alpha-1-antitrypsin, and high molecular weight kininogen (light chain) between the two groups of patients� samples. Our data are suggestive of the potential use of the serum proteins as complementary biomarkers to effectively discriminate PCa from BPH, although this requires further extensive validation on clinically representative populations. 2012 Article NonPeerReviewed application/pdf en http://eprints.um.edu.my/3461/1/Identification_of_potential_complementary_serum_biomarkers_to_differentiate_prostate_cancer_from_benign_prostatic_hyperplasia_using_gel-.pdf Jayapalan, J.J. and Ng, K.L. and Razack, A.H.A. and Hashim, Onn Haji (2012) Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel- and lectin-based proteomics analyses. Electrophoresis, 33 (12). pp. 1855-1862. ISSN 1522-2683 http://onlinelibrary.wiley.com/doi/10.1002/elps.201100608/full 10.1002/elps.201100608 |
institution |
Universiti Malaya |
building |
UM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Malaya |
content_source |
UM Research Repository |
url_provider |
http://eprints.um.edu.my/ |
language |
English |
topic |
R Medicine |
spellingShingle |
R Medicine Jayapalan, J.J. Ng, K.L. Razack, A.H.A. Hashim, Onn Haji Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel- and lectin-based proteomics analyses |
description |
Diagnosis of prostate cancer (PCa) is currently much reliant on the invasive and time-consuming transrectal ultrasound-guided biopsy of the prostate gland, particularly in light of the inefficient use of prostate-specific antigen as its biomarker. In the present study, we have profiled the sera of patients with PCa and benign prostatic hyperplasia (BPH) using the gel- and lectin-based proteomics methods and demonstrated the significant differential expression of apolipoprotein AII, complement C3 beta chain fragment, inter-alpha-trypsin inhibitor heavy chain 4 fragment, transthyretin, alpha-1-antitrypsin, and high molecular weight kininogen (light chain) between the two groups of patients� samples. Our data are suggestive of the potential use of the serum proteins as complementary biomarkers to effectively discriminate PCa from BPH, although this requires further extensive validation on clinically representative populations. |
format |
Article |
author |
Jayapalan, J.J. Ng, K.L. Razack, A.H.A. Hashim, Onn Haji |
author_facet |
Jayapalan, J.J. Ng, K.L. Razack, A.H.A. Hashim, Onn Haji |
author_sort |
Jayapalan, J.J. |
title |
Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel- and lectin-based proteomics analyses |
title_short |
Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel- and lectin-based proteomics analyses |
title_full |
Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel- and lectin-based proteomics analyses |
title_fullStr |
Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel- and lectin-based proteomics analyses |
title_full_unstemmed |
Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel- and lectin-based proteomics analyses |
title_sort |
identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel- and lectin-based proteomics analyses |
publishDate |
2012 |
url |
http://eprints.um.edu.my/3461/1/Identification_of_potential_complementary_serum_biomarkers_to_differentiate_prostate_cancer_from_benign_prostatic_hyperplasia_using_gel-.pdf http://eprints.um.edu.my/3461/ http://onlinelibrary.wiley.com/doi/10.1002/elps.201100608/full |
_version_ |
1648735996061155328 |
score |
13.15806 |